ANANDA And UCLA Start Trial For Nantheia™ ATL5
22 Oct 2024 //
BUSINESSWIRE
ANANDA Scientific Announces Trial For Nantheia™ ATL5 In Opioid Use
15 Oct 2024 //
BUSINESSWIRE
ANANDA Announce First Patient Enrolled in FDA Trial Evaluating Treatment for SAD
28 Mar 2023 //
BUSINESSWIRE
ANANDA Scientific Announces FDA Approval of IND for a Trial exploring of (SAD)
30 Nov 2022 //
BUSINESSWIRE
ANANDA Scientific Begins Enrollment in Trial on the Treatment of OUD
26 Jul 2022 //
PRNEWSWIRE
ANANDA Scientific Announces FDA approval of IND for Trial on Opioid Use Disorder
04 Jan 2022 //
BUSINESSWIRE
ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to Be Clinically
19 Oct 2021 //
BUSINESSWIRE
ANANDA Scientific & David Geffen School of Medicine UCLA to evaluate CBD for OUD
29 Sep 2021 //
BUSINESSWIRE
ANANDA & NYU Grossman School of Medicine`s update on cannabidiol Study
09 Jun 2021 //
BUSINESSWIRE
First Patient Enrolled in Trial Evaluating Liquid Structure™ Cannabidiol
08 Jun 2021 //
BUSINESSWIRE